-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Maintains Neutral on Tandem Diabetes Care, Lowers Price Target to $20

Benzinga·07/15/2026 18:35:01
Listen to the news
Mizuho analyst Anthony Petrone maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Neutral and lowers the price target from $24 to $20.